纳斯达克生物科技指数收涨1.46%，表现好于美股大盘指数

成分股NantKwest涨25.87%，Medpace涨19.67%，Nautilus Biotechnology、Revolution Med、Iovance Biotherapeutics、Adaptive Biotechnologies、ImmunoGen、奥麦罗制药、Altimmune涨17.09%-10.28%，Ardelyx涨9.25%，莱斯康制药也涨9.17%；C4则收跌8.44%，Mersana Therapeutics跌8.62%，Alaunos Therapeutics跌8.99%，Karyopharm Therapeutics跌9.85%，Pmv Pharma跌11.11%，Eiger BioPharmaceuticals跌14.66%。

来源：金融界AI电报